fructosamine has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cirule, H; Dambrova, M; Grinberga, S; Kalvinsh, I; Kuka, J; Liepinsh, E; Skapare, E; Svalbe, B; Vilskersts, R; Zvejniece, L | 1 |
| Szwergold, B | 1 |
2 other study(ies) available for fructosamine and cardiovascular agents
| Article | Year |
|---|---|
Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.
Topics: 3-Hydroxybutyric Acid; Administration, Oral; Animals; Blood Glucose; Cardiovascular Agents; Carnitine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructosamine; Heart; Hyperalgesia; Hypoglycemic Agents; In Vitro Techniques; Lipids; Male; Methylhydrazines; Myocardial Ischemia; Pain Threshold; Rats; Rats, Wistar | 2009 |
Reactions between methylglyoxal and its scavengers in-vivo appear to be catalyzed enzymatically.
Topics: Aldehydes; Carbon; Cardiovascular Agents; Catalysis; Diabetes Complications; Dihydroxyacetone; Fructosamine; Fructose-Bisphosphate Aldolase; Glutathione; Humans; Hydrogen-Ion Concentration; Kinetics; Metformin; Models, Biological; Pentoses; Phenotype; Polyphenols; Pyruvaldehyde | 2017 |